Sandro Ripa
Impact in
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Antimicrobial Resistance in Staphylococcus 18
- Co-authors
- Manuela Prenna (32 shared papers)Luca A. Vitali (13 shared papers)Pietro E. Varaldo (10 shared papers)Claudia Zampaloni (8 shared papers)Dezemona Petrelli (8 shared papers)Luigi Ferrante (11 shared papers)Fiorenzo Mignini (10 shared papers)Bruna Facinelli (3 shared papers)
- Journals
- Chemotherapy (8 papers)Antimicrobial Agents and Chemotherapy (5 papers)Journal of Clinical Microbiology (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (4 papers)Microbial Drug Resistance (2 papers)
- Partner nations
- ItalyUnited StatesCzechia
In The Last Decade
Sandro Ripa
50 papers receiving 744 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 344
- Molecular Medicine 91
- Clinical Biochemistry 93
- Applied Microbiology and Biotechnology 23
- Public Health, Environmental and Occupational Health 266
Countries citing papers authored by Sandro Ripa
This map shows the geographic impact of Sandro Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Ripa more than expected).
Fields of papers citing papers by Sandro Ripa
This network shows the impact of papers produced by Sandro Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Ripa. The network helps show where Sandro Ripa may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandro Ripa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 70 | |
| 2 | 2012 | 55 | |
| 3 | 2006 | 47 | |
| 4 | 2008 | 39 | |
| 5 | 2008 | 39 | |
| 6 | 2001 | 39 | |
| 7 | 1984 | 37 | |
| 8 | 2012 | 36 | |
| 9 | In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp. | 1987 | 35 |
| 10 | 2003 | 31 | |
| 11 | 2012 | 29 | |
| 12 | 2004 | 25 | |
| 13 | 1982 | 25 | |
| 14 | 2009 | 21 | |
| 15 | 1993 | 16 | |
| 16 | 2010 | 16 | |
| 17 | 1998 | 15 | |
| 18 | 1997 | 15 | |
| 19 | 2010 | 14 | |
| 20 | 2000 | 14 |
About Sandro Ripa
Sandro Ripa is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 54 papers that have together received 788 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Streptococcal Infections and Treatments (13 papers), Antibiotic Resistance in Bacteria (11 papers), Infective Endocarditis Diagnosis and Management (8 papers), Pneumonia and Respiratory Infections (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Infectious Diseases (344 citations), Molecular Medicine (91 citations), Clinical Biochemistry (93 citations), Applied Microbiology and Biotechnology (23 citations) and Public Health, Environmental and Occupational Health (266 citations). Sandro Ripa has collaborated with scholars based in Italy, United States and Czechia. Frequent co-authors include Manuela Prenna, Luca A. Vitali, Pietro E. Varaldo, Claudia Zampaloni, Dezemona Petrelli, Luigi Ferrante, Fiorenzo Mignini, Bruna Facinelli, Gloria Magi and Marina Mingoia. Their work appears in journals such as Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, European Journal of Clinical Microbiology & Infectious Diseases and Microbial Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.